From: Assessing the accuracy of [18F]PSMA-1007 PET/CT for primary staging of lymph node metastases in intermediate- and high-risk prostate cancer patients
PAD positive
PAD negative
Total
Intermediate risk
PSMA positive
0
1
PSMA negative
6
17
23
High risk
7
2
9
13
58
71
26
78
104